These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 36369228)
1. HER2 status based on breast cancer guidelines as a useful prognostic marker of T2 gallbladder cancer. Kwon CH; Seo HI; Kim DU; Han SY; Kim S; Lee SJ; Jeon DY Eur J Surg Oncol; 2023 Feb; 49(2):392-398. PubMed ID: 36369228 [TBL] [Abstract][Full Text] [Related]
2. Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer. Stocker A; Trojan A; Elfgen C; Hilbers ML; Moskovszky L; Varga Z Breast Cancer Res Treat; 2020 Sep; 183(2):311-319. PubMed ID: 32638236 [TBL] [Abstract][Full Text] [Related]
3. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer. He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643 [TBL] [Abstract][Full Text] [Related]
4. High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients. Kong Y; Dai S; Xie X; Xiao X; Lv N; Guo J; Li L; Jia W; Zhang Y; Liu W; Wei W; Xie X J Cancer Res Clin Oncol; 2012 Feb; 138(2):275-84. PubMed ID: 22116318 [TBL] [Abstract][Full Text] [Related]
5. A significant subgroup of resectable gallbladder cancer patients has an HER2 positive status. Yoshida H; Shimada K; Kosuge T; Hiraoka N Virchows Arch; 2016 Apr; 468(4):431-9. PubMed ID: 26758058 [TBL] [Abstract][Full Text] [Related]
6. Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients. Dressler LG; Berry DA; Broadwater G; Cowan D; Cox K; Griffin S; Miller A; Tse J; Novotny D; Persons DL; Barcos M; Henderson IC; Liu ET; Thor A; Budman D; Muss H; Norton L; Hayes DF J Clin Oncol; 2005 Jul; 23(19):4287-97. PubMed ID: 15994142 [TBL] [Abstract][Full Text] [Related]
7. HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma. Albrecht T; Rausch M; Roessler S; Geissler V; Albrecht M; Halske C; Seifert C; Renner M; Singer S; Mehrabi A; Vogel MN; Pathil-Warth A; Busch E; Köhler B; Rupp C; Weiss KH; Springfeld C; Röcken C; Schirmacher P; Goeppert B Virchows Arch; 2020 Jun; 476(6):871-880. PubMed ID: 31838585 [TBL] [Abstract][Full Text] [Related]
8. Estimating the influencing factors for T1b/T2 gallbladder cancer on survival and surgical approaches selection. Cao J; Yan J; Hu J; Zhang B; Topatana W; Li S; Chen T; Jeungpanich S; Lu Z; Peng S; Cai X; Chen M Cancer Med; 2023 Aug; 12(16):16744-16755. PubMed ID: 37366278 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of VEGF, PDGF-B, and HER2/neu expression in gallbladder cancer. Shukla P; Mishra K; Shukla R; Vishwakarma R; Kumari N; Krishnani N; Behari A; Kapoor VK J Cancer Res Ther; 2024 Jan; 20(1):349-357. PubMed ID: 38554345 [TBL] [Abstract][Full Text] [Related]
10. Analysis of HER2 by chromogenic in situ hybridization and immunohistochemistry in lymph node-negative breast carcinoma: Prognostic relevance. Peiró G; Aranda FI; Adrover E; Niveiro M; Alenda C; Payá A; Seguí J Hum Pathol; 2007 Jan; 38(1):26-34. PubMed ID: 17056098 [TBL] [Abstract][Full Text] [Related]
11. Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study. Cho JK; Lee W; Jang JY; Kim HG; Kim JM; Kwag SJ; Park JH; Kim JY; Park T; Jeong SH; Ju YT; Jung EJ; Lee YJ; Hong SC; Jeong CY World J Surg Oncol; 2019 Jan; 17(1):8. PubMed ID: 30616645 [TBL] [Abstract][Full Text] [Related]
12. Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding. Cavallaro A; Piccolo G; Panebianco V; Lo Menzo E; Berretta M; Zanghì A; Di Vita M; Cappellani A World J Gastroenterol; 2012 Aug; 18(30):4019-27. PubMed ID: 22912553 [TBL] [Abstract][Full Text] [Related]
13. HER-2 overexpression in female genital tract clear cell carcinomas: Evaluation of different scoring guidelines, clinicopathological features and prognostic impact. Edjtemaei R; Nili F; Jahanzad I; Ameli F; Ghasemi D Ann Diagn Pathol; 2023 Oct; 66():152184. PubMed ID: 37543027 [TBL] [Abstract][Full Text] [Related]
14. Long-Term Oncologic Outcomes for T2 Gallbladder Cancer According to the Type of Surgery Performed and the Optimal Timing for Sequential Extended Cholecystectomy. Oh MY; Kim H; Sohn HJ; Lee S; Lee M; Kim HS; Han Y; Kwon W; Jang JY J Gastrointest Surg; 2022 Aug; 26(8):1705-1712. PubMed ID: 35641810 [TBL] [Abstract][Full Text] [Related]
15. Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization. Vinatzer U; Dampier B; Streubel B; Pacher M; Seewald MJ; Stratowa C; Kaserer K; Schreiber M Clin Cancer Res; 2005 Dec; 11(23):8348-57. PubMed ID: 16322295 [TBL] [Abstract][Full Text] [Related]
16. Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial. Loi S; Dafni U; Karlis D; Polydoropoulou V; Young BM; Willis S; Long B; de Azambuja E; Sotiriou C; Viale G; Rüschoff J; Piccart MJ; Dowsett M; Michiels S; Leyland-Jones B JAMA Oncol; 2016 Aug; 2(8):1040-7. PubMed ID: 27100299 [TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features and prognosis of breast cancer with human epidermal growth factor receptor 2 low expression]. Zhu XJ; Zhang H; Zhang S; Li D; Li X; Xu L; Li T Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):243-253. PubMed ID: 37042134 [TBL] [Abstract][Full Text] [Related]
18. HER2 Positivity Is Affected by the Papillary Structure and Has a Bidirectional Prognostic Value for Gallbladder Carcinoma. Chen L; Xu L; Shen L; Luo R; Jiang D; Wang Y; Li W; Hou Y Front Genet; 2021; 12():831318. PubMed ID: 35265100 [TBL] [Abstract][Full Text] [Related]
19. Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer. Kammori M; Kurabayashi R; Kashio M; Sakamoto A; Yoshimoto M; Amano S; Kaminishi M; Yamada T; Takubo K Oncol Rep; 2008 Mar; 19(3):651-6. PubMed ID: 18288397 [TBL] [Abstract][Full Text] [Related]
20. Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer. Hryciuk B; Pęksa R; Bieńkowski M; Szymanowski B; Radecka B; Winnik K; Żok J; Cichowska N; Iliszko M; Duchnowska R Sci Rep; 2020 Feb; 10(1):1871. PubMed ID: 32024900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]